Item Type No Grouping

Article

A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension. (2016) Nura A. Mohamed, Blerina Ahmetaj-Shala, Lucie Duluc, Louise S. Mackenzie, Nicholas S. Kirkby, Daniel M. Reed, Paul D. Lickiss, Robert P. Davies, Gemma R. Freeman, Beata Wojciak-Stothard, Adrian H. Chester, Ibrahim M. El-Sherbiny, Jane A. Mitchell and Magdi H. Yacoub

Reply to Letter Regarding Article, "Evidence That Links Loss of Cyclooxygenase-2 With Increased Asymmetric Dimethylarginine : Novel Explanation of Cardiovascular Side Effects Associated With Anti-Inflammatory Drugs". (2015) Blerina Ahmetaj-Shala, Nicholas S. Kirkby, Rebecca Knowles, Malak Al'Yamani, Sara Mazi, Zhen Wang, Arthur T. Tucker, Louise Susan Mackenzie, Paul C. J. Armstrong, Rolf M. Nüsing, James A. P. Tomlinson, Timothy D. Warner, James Leiper and Jane A. Mitchell

Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine : novel explanation of cardiovascular side effects associated with anti-inflammatory drugs. (2015) Blerina Ahmetaj-Shala, Nicholas S. Kirkby, Rebecca Knowles, Malak Al'Yamani, Sarah Mazi, Zhen Wang, Arthur T. Tucker, Louise Mackenzie, Paul C. J. Armstrong, Rolf M. Nüsing, James A. P. Tomlinson, Timothy D. Warner, James Leiper and Jane A. Mitchell

Role of prostacyclin in pulmonary hypertension. (2014) Jane A. Mitchell, Blerina Ahmetaj-Shala, Nick Kirkby, William R. Wright, Louise Susan MacKenzie, Dan Reed and Nura Mohamed

Aspirin triggered 15-epi-lipoxin A4 predicts cyclo-oxygenase-2 in the lungs of LPS treated mice but not in the circulation : implications for a clinical test. (2013) Nick Kirkby, M.V. Chan, M.H. Lundberg, Louise MacKenzie, Phillip D.M. Leadbeater, Ginger L. Milne, Claire M. Potter, Malak Al-Yamani, Oladipupo Adeyemi, Tim D. Warner and Jane A. Mitchell

Not so EEZE : the ‘EDHF’ antagonist 14, 15 Epoxyeicosa-5(z)-enoic Acid has vasodilator properties in mesenteric arteries. (2004) Louise Susan MacKenzie, John R. Falck and Jane A. Mitchell

Other

Nitric oxide-dependent vasodilation is compromised in isolated pulmonary arteries from COX knockout mice. (2013) Will Wright, Louise Susan MacKenzie, N.S. Kirkby and Jane A. Mitchell

Contribution of COX1 and COX2 to prostacyclin release by healthy mouse tissues. (2011) N.S. Kirkby, Louise Harrington, Martina Lundberg, T. Hoefer, Tim D. Warner and Jane A. Mitchell

COX-1 or COX-2 deletion is associated with increased nuclear NF-κB in the endothelium of the aortic arch. (2010) Martina Lundberg, Louise Susan Harrington, Phillip D.M. Leadbeater, Tim D. Warner and Jane A. Mitchell

COX isoforms in aortic endothelial cells from young adult and mature adult mice. (2009) M.H. Lundberg, Louise Susan MacKenzie, Ivana Vojnovic, Timothy D. Warner and Jane A. Mitchell

Relative expression of cyclo-oxygenase COX-1 and COX-2 in porcine endothelium subjected to chronic shear stress. (2009) Claire M.F. Potter, Martina H. Lundberg, Louise Susan MacKenzie, C.M. Warboys, Hime Gashaw, Timothy D. Warner, P.D. Weinberg and Jane A. Mitchell

The ‘EDHF’ Antagonist 14, 15 Epoxyeicosa-5(Z)-Enoic Acid has Vasodilator Properties in Mesenteric Vessels. (2004) Louise Susan MacKenzie, John R. Falck and Jane A. Mitchell